Biomedicines (Oct 2022)

Plasma and Peritoneal Fluid ZEB Levels in Patients with Endometriosis and Infertility

  • Paweł Bartnik,
  • Joanna Kacperczyk-Bartnik,
  • Ksawery Goławski,
  • Janusz Sierdziński,
  • Grzegorz Mańka,
  • Mariusz Kiecka,
  • Michał Lipa,
  • Damian Warzecha,
  • Robert Spaczyński,
  • Piotr Piekarski,
  • Beata Banaszewska,
  • Artur J. Jakimiuk,
  • Tadeusz Issat,
  • Wojciech Rokita,
  • Jakub Młodawski,
  • Maria Szubert,
  • Piotr Sieroszewski,
  • Grzegorz Raba,
  • Kamil Szczupak,
  • Tomasz Kluz,
  • Marek Kluza,
  • Krzysztof Czajkowski,
  • Mirosław Wielgoś,
  • Ewa Koc-Żórawska,
  • Marcin Żórawski,
  • Piotr Laudański

DOI
https://doi.org/10.3390/biomedicines10102460
Journal volume & issue
Vol. 10, no. 10
p. 2460

Abstract

Read online

Zinc finger E-box-binding homeobox 1 (ZEB1) and zinc finger E-box-binding homeobox 2 (ZEB2) are transcription factors that regulate epithelial–mesenchymal transformation (EMT). The aim of this study was to compare levels of ZEB1 and ZEB2 in the peritoneal fluid and plasma between patients with and without endometriosis in order to assess their utility in the diagnostic process. Plasma and peritoneal fluid samples were collected from 50 patients with and 48 without endometriosis during planned surgical procedures in eight clinical centers. Quantitative ZEB1 and ZEB2 levels analyses were performed using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). No significant differences were observed in ZEB1 levels in any of the subanalyses nor any differences regarding ZEB2 levels between patients with and without endometriosis. Plasma ZEB2 levels were significantly higher among patients with infertility compared to fertile women (16.07 ± 12.70 ng/L vs. 12.07 ± 11.92 ng/L; p < 0.04). Both ZEB1 and ZEB2 do not seem to have a significant value in the initial diagnosis of endometriosis as a single marker. The differences in ZEB2 plasma levels between patients with and without infertility indicate the possibility of EMT dysregulation in the pathogenesis of adverse fertility outcomes.

Keywords